Results 321 to 330 of about 2,956,994 (356)

Enhancing De Novo Drug Design across Multiple Therapeutic Targets with CVAE Generative Models. [PDF]

open access: yesACS Omega
Romanelli V   +5 more
europepmc   +1 more source

NMR-Based Rational Drug Design of G:G Mismatch DNA Binding Ligand Trapping Transient Complex via Disruption of a Key Allosteric Interaction. [PDF]

open access: yesJ Am Chem Soc
Sakurabayashi S   +11 more
europepmc   +1 more source

New Designer Drugs

Emergency Medicine Clinics of North America, 2021
In recent years, there has been an emergence of numerous novel drugs. Such toxicity may occur in both adolescents and adults. This article discusses the opioid epidemic and several emerging opioids, including buprenorphine, loperamide, fentanyl, fentanyl derivatives, and others.
Michael Levine, Frank Lovecchio
openaire   +2 more sources

Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs

Combinatorial Chemistry & High Throughput Screening, 2015
Due to the time and effort requirements for the development of a new drug, and the high attrition rates associated with this developmental process, there is an intense effort by academic and industrial researchers to find novel ways for more effective drug development schemes.
Kellici T   +13 more
openaire   +3 more sources

VIP and Drug Design

Current Pharmaceutical Design, 2003
The following review outlines the physiological outcome of VIP and VIP gene manipulations. Previously, we reviewed the various VIP receptors associated with biological functions ranging from growth regulation, sexual function, bronchodilation, vasodilation and immune interactions to neurotrophism. VIP-based drug design is discussed below.
Illana Gozes, Sharon Furman
openaire   +3 more sources

Rational drug design

European Journal of Pharmacology, 2009
In this article, current knowledge of drug design is reviewed and an approach of rational drug design is presented. The process of drug development is challenging, expensive, and time consuming, although this process has been accelerated due to the development of computational tools and methodologies.
Meenal Moudgil   +3 more
openaire   +3 more sources

NMR in drug design

Archives of Biochemistry and Biophysics, 2017
The use of NMR as a tool to determine 3 dimensional protein solution structures, once a darling of the pharmaceutical industry, has largely given way to study of the interaction of prospective drugs with macromolecular targets. Many of these approaches involve ligand-centered studies, which have the advantage of speed and efficiency, but there are also
Luciano Mueller   +3 more
openaire   +3 more sources

Parachors in drug design

Biochemical Pharmacology, 1975
Abstract Parachor has been used extensively in physical organic chemistry for structure determination. It has rarely been used as a parameter for the correlation of structure and biological activity. We have reexamined the parachor concept for structure-activity correlations of some closely related analogs.
Alan Mellors   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy